Forward P/S Multiple: Avinger (AVGR)

Avinger, Inc. - graphic logo of issuer AVGR

Avinger, Inc. generates revenue from the sale of visualization systems and consumables for minimally invasive vascular treatment. The forward P/S trajectory reflects market expectations, where 0.20 represents the current level of the metric. The company's success relies on the demand for Pantheris systems and sensor precision. Growth is supported by the robotization of laser catheter production and the implementation of AI-driven processing for diagnostic imaging.

avinger.com - AVGR Market Cap to Projected Revenue (period 07/04/2022 - 02/22/2025)

Summary analytical data breakdowns for Avinger Inc (AVGR)

- market price and analyst price targets:
Price Chart Avinger|AVGR - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization Avinger Inc|AVGR - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Avinger|AVGR - Accounting Capitalization|Market Capitalization to Book Value Ratio avinger.com|AVGR - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Avinger, Inc.|AVGR - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Avinger, Inc.|AVGR - Company Aggregate Debts|Debt to Book Capitalization Ratio Avinger Inc|AVGR - Company Long-Term Debt|Company Current Liabilities Avinger|Quick Ratio avinger.com
- financial results and valuation multiples details:
AVGR - Company Net Income|Expected Profit Avinger, Inc.|AVGR - Market Cap to Net Income Ratio|Projected Price to Earnings Avinger, Inc|AVGR - PEG Multiple|EV/EBITDA Multiple Avinger Inc|AVGR - Operating income before deduction of amortization|Earnings per share for the last twelve months Avinger|AVGR - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months avinger.com|AVGR - Net earnings per share growth this year|Earnings growth forecast for next year Avinger, Inc.
- sales and revenue indicators:
AVGR - Company Total Revenue|Company Projected Revenue Avinger|AVGR - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple Avinger Inc
Fundamental company analysis:AVGR (Avinger)
Product sample of Avinger Inc

The forward P/S reflects the market value of the business relative to expected annual sales volume, allowing for an assessment of the premium or discount to projected cash flows. By analyzing the forward P/S trend, an investor can see how market expectations are adjusting amid the slow adoption of Avinger, Inc. (AVGR) catheters in US clinics and liquidity shortage risks resulting from the company's operating losses.

Who Avinger, Inc. competes with

Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio AVITA Medical (RCEL)|profoundmedical.com (PROF) - Projected Price to Revenue|Baird Medical - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP TMS SA EDAP|Bovie Medical - Forward P/S Multiple|Market Cap to Expected Sales Ratio IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Price-to-Projected Revenue Ratio|Future Price to Revenue TELA (TELA Bio)|Price-to-Projected Revenue Ratio CytoSorbents Corp|Forward Price-to-Revenue Multiple Sensus (SRTS)|Forward P/S Multiple ZYXI|ECOR - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Vicarious Surgical RBOT|IINN: Market Cap to Projected Revenue|ICU: Forward Price-to-Revenue Multiple|IRIDEX Corporation - Price to Expected Revenue Ratio|INBS: Forward P/S Multiple|Beyond Air (XAIR) - Forward P/S Multiple|Forward Price-to-Revenue Multiple PFSA|Price-to-Projected Revenue Ratio SSKN|Forward P/S Multiple GCTK|Market Cap to Expected Sales Ratio NanoVibronix Inc.|Price-to-Projected Revenue Ratio Venus Concept Inc. VERO|NUWE: Market Cap to Projected Revenue|Aethlon Medical, Inc. - Forward P/S Multiple|Projected Price to Revenue Asensus Surgical, Inc. (ASXC)|BSGM: Forward P/S Multiple|Market Cap to Future Revenue Ratio Cutera Inc (CUTR)|Price-to-Projected Revenue Ratio Know Labs, Inc.|NARI: Forward Price to Sales|Forward Price-to-Revenue Multiple NVRO (Nevro)|RSLS (reshapelifesciences.com) - Forward Price to Sales|Forward P/S Multiple SILK (Silk Road Medical Inc.)